In English | En español
Questions About Cancer? 1-800-4-CANCER

Cancer Drug Information

  • Posted: 10/05/2006
  • Updated: 11/18/2013

Page Options

  • Print This Page
  • Email This Document

Paclitaxel Albumin-stabilized Nanoparticle Formulation

listen  (PA-klih-TAK-sil al-BYOO-min-STAY-bih-lized NA-noh-PAR-tih-kul for-myoo-LAY-shun)

This page contains brief information about paclitaxel albumin-stabilized nanoparticle formulation and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s): Abraxane
FDA Approved: Yes

FDA Approval for Paclitaxel Albumin-stabilized Nanoparticle Formulation

Use in Cancer

Paclitaxel albumin-stabilized nanoparticle formulation is approved to be used alone or with other drugs to treat:

Paclitaxel albumin-stabilized nanoparticle formulation is also being studied in the treatment of other types of cancer.

Paclitaxel albumin-stabilized nanoparticle formulation is a form of paclitaxel contained in nanoparticles (very tiny particles of protein). The drug is also called nanoparticle paclitaxel and protein-bound paclitaxel. This form may work better than other forms of paclitaxel and have fewer side effects. For more information about paclitaxel that may apply to paclitaxel albumin-stabilized nanoparticle formulation, see the Drug Information Summary for Paclitaxel.

More About Paclitaxel Albumin-stabilized Nanoparticle Formulation

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

MedlinePlus Information on Paclitaxel - A lay language summary of important information about this drug that may include the following:

  • warnings about this drug,
  • what this drug is used for and how it is used,
  • what you should tell your doctor before using this drug,
  • what you should know about this drug before using it,
  • other drugs that may interact with this drug, and
  • possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Research Results

Clinical Trial Results: Combination of Nab-Paclitaxel and Gemcitabine Improves Survival in Patients With Metastatic Pancreatic Cancer - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trials Accepting Patients

Find Clinical Trials for Paclitaxel Albumin-stabilized Nanoparticle Formulation - Check for trials from NCI's list of cancer clinical trials now accepting patients.

Important: The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.


Back to TopBack to Top